US 2003/0003565 A1Published application

Functional lentiviral vector from an MLV-based backbone

OwnerThomas W. Dubensky JR., Mehdi Gasmi +1inventors

InventorsThomas W. Dubensky JR., Mehdi Gasmi, Sybille Sauter

Life of this patent

Estimating the term…

Abstract

Disclosed are gene therapy vectors based on chimeric murine leukemia virus-feline immunodeficiency virus gene therapy vectors which are suitable for a wide variety of gene therapy applications. Also disclosed are related packaging cell lines, methods for production, and methods of use.

Claims30

Dependent claims

A chimeric murine leukemia virus (MLV)-feline leukemia virus (FIV) vector construct, comprising an MLV vector backbone and an FIV vector construct.

Dependencies are inferred from the claim text.

Facts

Application: 09/996,073Filed 27 Nov 2001
Priority: 27 Nov 2000
Published: 2 Jan 2003
Term ends: Not estimatedThe source records don’t support an estimate.

Classification10 codes

C12N 15/86
For animal cells: viral vectors
A61K 48/00
Medicinal preparations containing genetic material which is inserted into cells of the
A61K 2039/525
Comprising whole cells, viruses or DNA/RNA: virus
C12N 2740/13044
Use of virus, viral particle or viral elements as a vector: chimeric viral vector comprising heterologous viral elements for production of another…

Family

Application60/253,419Us provisional application · filed 27 Nov 2000
US 2003/0003565 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results